866-997-4948(US-Canada Toll Free)

Veterinary Therapeutics Market - Kingdom of Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 95 Pages

Kingdom of Saudi Arabia Veterinary Therapeutics Market: Overview

This report on the KSA veterinary therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the KSA veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

Kingdom of Saudi Arabia Veterinary Therapeutics Market: Drivers and Restraints

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the KSA veterinary therapeutics market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Kingdom of Saudi Arabia Veterinary Therapeutics Market: Segments

Based on product type, the KSA veterinary therapeutics market has been segmented into pharmaceuticals (ectoparasiticides, endoparasiticides, antibiotics, anti-inflammatories, and endectocides), vaccines (bacterial vaccines, and viral vaccines), nutritional feed additives (amino acids, vitamins, and minerals), and disinfectants (floor disinfectants, and disinfectants used in tissues). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals.

This report provides in-depth analysis of the veterinary therapeutics market. The stakeholders for this report include pharmaceutical companies providing veterinary medicines. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different product type and animal type. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the KSA veterinary therapeutics market. Furthermore, the report incorporates market attractiveness analysis by product type and animal type that depicts the most attractive and significant segments in the KSA market in 2016.

Key Players Mentioned in this Report are:

The report also comprises list major global players in the market, their SWOT analysis, market share of these players in the veterinary therapeutics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc

The KSA veterinary therapeutics market has been segmented as follows:

KSA Veterinary Therapeutics Market, by Product Type

  • Pharmaceuticals
  • Ectoparasiticides
  • Endoparasiticides
  • Antibiotics
  • Anti-inflammatories
  • Endectocides
  • Vaccines
  • Bacterial
  • Viral
  • Nutritional Feed Additives
  • Amino Acids
  • Vitamins
  • Minerals
  • Disinfectants
  • Floor Disinfectants
  • Disinfectants Used in Tissues

KSA Veterinary Therapeutics Market, by Animal Type

  • Companion
  • Cats
  • Dogs
  • Livestock
  • Cattle
  • Sheep
  • Poultry

Table of Content

Chapter 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. KSA Veterinary Therapeutics: Market Snapshot
3.2. Market Share Analysis by Region, 2016

Chapter 4. Market Overview
4.1. Product Overview
4.2. KSA Veterinary Therapeutics Market : Market Indicators

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increased meat consumption and demand for high quality proteins
5.2.2. Government support for animal feed import
5.2.3. Easy availability of antibiotics
5.2.4. Current livestock disease outbreaks fueling feed additive usage
5.2.5. Increase in ownership of companion animals
5.3. Restrains
5.3.1. Low R&D returns
5.3.2. Ban on antibiotics due to its harmful effects
5.4. Opportunities
5.4.1. Growing awareness and affordability of therapeutics for pets and livestock offer significant opportunities to new entrants
5.4.2. Increasing price of feed products can result in higher demand for feed additives
5.5. Key Trends
5.5.1. Import of feed additives and meat
5.5.2. Saudi Arabia's broiler production to expand

Chapter 6. Market Outlook
6.1. KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2015–2025
6.2. KSA Veterinary Therapeutics Market Outlook, By Product & Animal
6.3. KSA Government Regulations for Veterinary Products
6.4. Saudi Arabia - Market Entry Strategy
6.5. KSA Veterinary Therapeutics Market: Imports & Local Production Overview
6.6. Value Chain Analysis

Chapter 7. KSA Veterinary Therapeutics Market Analysis, by Pharmaceuticals Product Type
7.1. Introduction
7.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Pharmaceuticals Product Type
7.3. KSA Veterinary Therapeutics Market Forecast, by Pharmaceuticals Product Type
7.3.1. Ectoparasiticides
7.3.2. Endoparasiticides
7.3.3. Antibiotics
7.3.4. Anti-inflammatories
7.3.5. Endectocides
7.4. Porter’s Five Forces Analysis

Chapter 8. KSA Veterinary Therapeutics Market Analysis, by Vaccines Product Type
8.1. Introduction
8.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Vaccines Product Type
8.3. KSA Veterinary Therapeutics Market Forecast, by Vaccines Product Type
8.3.1. Bacterial Vaccines
8.3.2. Viral Vaccines
8.4. Porter’s Five Forces Analysis

Chapter 9. KSA Veterinary Therapeutics Market Analysis, by Nutritional Feed Additives Product Type
9.1. Introduction
9.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Nutritional Feed Additives Product Type
9.3. KSA Veterinary Therapeutics Market Forecast, by Nutritional Feed Additives Product Type
9.3.1. Amino Acids
9.3.2. Vitamins
9.3.3. Minerals
9.4. Porter’s Five Forces Analysis

Chapter 10. KSA Veterinary Therapeutics Market Analysis, by Disinfectants Product Type
10.1. Introduction
10.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Disinfectants Product Type
10.3. KSA Veterinary Therapeutics Market Forecast, by Disinfectants Product Type
10.3.1. Floor Disinfectants
10.3.2. Disinfectants Used in Tissues
10.4. Porter’s Five Forces Analysis
10.5. KSA Veterinary Therapeutics Market Attractiveness Analysis, by Product Type

Chapter 11. KSA Veterinary Therapeutics Market Analysis, by Companion Animal Type
11.1. Introduction
11.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Companion Animal Type
11.3. KSA Veterinary Therapeutics Market Forecast, by Companion Animal Type
11.3.1. Cats
11.3.2. Dogs

Chapter 12. KSA Veterinary Therapeutics Market Analysis, by Livestock Animal Type
12.1. Introduction
12.2. KSA Veterinary Therapeutics Market Value Share Analysis, by Livestock Animal Type
12.3. KSA Veterinary Therapeutics Market Forecast, by Livestock Animal Type
12.4. KSA Veterinary Therapeutics Market Attractiveness Analysis, by Animal
12.4.1. Cattle
12.4.2. Sheep
12.4.3. Poultry

Chapter 13. Company Profiles
13.1. Global Veterinary Therapeutics Market Share Analysis, by Company
13.2. KSA Veterinary Therapeutics Market Share Analysis, by Company
13.3. Competition Matrix
13.4. Company profiles
13.4.1. Bayer AG
13.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.1.2. Financial Overview
13.4.1.3. Product Portfolio
13.4.1.4. SWOT Analysis
13.4.1.5. Strategic Overview
13.4.2. Boehringer Ingelheim GmbH
13.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.2.2. Financial Overview
13.4.2.3. Product Portfolio
13.4.2.4. SWOT Analysis
13.4.2.5. Strategic Overview
13.4.3. Ceva Santé Animale
13.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.3.2. Financial Overview
13.4.3.3. Product Portfolio
13.4.3.4. SWOT Analysis
13.4.3.5. Strategic Overview
13.4.4. Dechra Pharmaceuticals plc
13.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.4.2. Financial Overview
13.4.4.3. Product Portfolio
13.4.4.4. SWOT Analysis
13.4.4.5. Strategic Overview
13.4.5. Eli Lilly and Company (Elanco Animal Health)
13.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.5.2. Financial Overview
13.4.5.3. Product Portfolio
13.4.5.4. SWOT Analysis
13.4.5.5. Strategic Overview
13.4.6. Merck Animal Health
13.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.6.2. Financial Overview
13.4.6.3. Product Portfolio
13.4.6.4. SWOT Analysis
13.4.6.5. Strategic Overview
13.4.7. Virbac
13.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.7.2. Financial Overview
13.4.7.3. Product Portfolio
13.4.7.4. SWOT Analysis
13.4.7.5. Strategic Overview
13.4.8. Vetoquinol S.A.
13.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.8.2. Financial Overview
13.4.8.3. Product Portfolio
13.4.8.4. SWOT Analysis
13.4.8.5. Strategic Overview
13.4.9. Zoetis, Inc.
13.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.9.2. Financial Overview
13.4.9.3. Product Portfolio
13.4.9.4. SWOT Analysis

List of Table

Table 01: KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Pharmaceuticals Product Type, 2015–2025
Table 02: KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Vaccines Product Type, 2015–2025
Table 03: KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Nutritional Feed Additives Product Type, 2015–2025
Table 04: KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Disinfectants Product Type, 2015–2025
Table 05: KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Companion Animal Type, 2015–2025
Table 06: KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Livestock Animal Type, 2015–2025

List of Chart

Figure 01: KSA Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: KSA Veterinary Therapeutics Market Value Share, by Product Type (2016)
Figure 03: KSA Veterinary Therapeutics Market Value Share, by Animal Type (2016)
Figure 04: KSA Veterinary Therapeutics Market Value Share, by Pharmaceuticals Product Type, 2017 and 2025
Figure 05: KSA Veterinary Therapeutics Market Value Share, by Vaccines Product Type, 2017 and 2025
Figure 06: KSA Veterinary Therapeutics Market Value Share, by Nutritional Feed Additives Product Type, 2017 and 2025
Figure 07: KSA Veterinary Therapeutics Market Value Share, by Disinfectants Product Type, 2017 and 2025
Figure 08: KSA Veterinary Therapeutics Market Attractiveness Analysis, by Product Type
Figure 09: KSA Veterinary Therapeutics Market Value Share, by Companion Animal Type, 2017 and 2025
Figure 10: KSA Veterinary Therapeutics Market Value Share, by Livestock Animal Type, 2017 and 2025
Figure 11: KSA Veterinary Therapeutics Market Attractiveness Analysis, by Animal
Figure 12: Global Veterinary Therapeutics Market Share Analysis, by Company (2016)
Figure 13: KSA Veterinary Therapeutics Market Ranking, by Company (2016)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *